SuRo Capital Corp. Common Stock (SSSS)

FairStock Score: 48/100 — MIXED

Key Financials

Strengths

• High return on equity of 26.9% demonstrating efficient capital deployment
• Conservative balance sheet with debt-to-equity of just 0.34, providing financial flexibility
• Attractive 3.8% dividend yield providing steady income returns

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Revenue declining at 491.4% year-over-year signals potential demand weakness or market share loss
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

SuRo Capital Corp. Common Stock is a micro-cap financial services company valued at $337 million. Revenue stands at $2 million, though the company is currently unprofitable. From a quality standpoint, SuRo shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and Altman Z-Score of 2.8 in the grey zone. On valuation, the stock is deeply undervalued on a P/E basis at 7.4x, with a modest 26% margin of safety vs Graham Number. Growth dynamics show revenue growing at -491.4% and profit growth of -45308.8%. The 3.8% dividend yield adds an income component for patient holders. Our composite FairStock Score of 48/100 reflects mixed fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.

Bull Case

The market underappreciates SuRo's consistent 27% ROE at just 7x earnings—a re-rating toward sector peers could unlock 30-50% upside. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer